Up to 90% of hospitalized patients will receive IV therapy. Between 35–50% of peripheral IV catheters fail due to infiltration, accidental dislodgment, blockage, phlebitis, or other causes.

I.V. House can help.

I.V. House’s ergonomically designed IV related joint stabilization and IV insertion site protection products allow nurses to quickly and thoroughly inspect the IV catheter to check for signs of complication such as changes in color, swelling, and temperature.

Up to 90% of hospitalized patients receive IV therapy, with overall failure rates between 35-50%.

By stabilizing the affected joint and protecting the IV insertion site, I.V. House products reduce the need for painful and time-consuming IV restarts caused by accidental dislodgment, infiltration and extravasation.

Nurses are the first line of defense against hospital acquired conditions that can lead to serious patient harm.

All I.V. House® products allow nurses to visually inspect and touch the IV insertion site and surrounding tissues quickly and effectively so they can identify the signs of complications, for instance changes in color, size or temperature. And recent trials are showing promising outcomes.

Results of a recent trial at St. Louis Children’s Hospital showed ZERO IV infiltrates in the patients wearing the TLC Splint compared to 12 IV infiltrates in the patients wearing traditional armboards.

750LFP I.V. House UltraDome Plus on child's hand

949SX IV House TLC Foot Splint on Infant's Foot

All I.V. House products are ISO 9001 certified.


Sign up to our newsletter to receive the latest industry news, research papers and information about FloMedical.

Scroll to Top